Tus kws kho mob
QP24-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective June 1, 2021
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 14, 2021
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1621 - 1630 ntawm 4303
Tus kws kho mob
QP26-21 Commercial Pharmacy Benefit Exclusion for Select Medications
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 14, 2021
Tus kws kho mob
QP30-21 Reference Guides for Commercial Networks and Medicare Products
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 14, 2021
Tus kws kho mob
QP29-21 Commercial and MHCP Pharmacy Benefit Update – Growth Hormone Notification
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 14, 2021
Tus kws kho mob
QP31-21 Update for New to Market Medical Drugs: Avalglucosidase Alfa and Selexipag (Uptravi intravenous formulation)
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 14, 2021
Tus kws kho mob
QP28-21 Commercial Pharmacy Benefit Exclusion for Select Medications and Formulary Alternatives
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 14, 2021
Tus kws kho mob
QP70-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective November 1, 2021
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 08, 2021
Tus kws kho mob
QP65R1-21 Update: Minnesota Health Care Programs Providers use of the Interactive Care Reviewer
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 08, 2021
Tus kws kho mob
QP69-21 Update for New to Market Medical Drugs: Ciltacabtagene Autoleucel
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 08, 2021